INS and metabolic dysfunction-associated steatotic liver disease: Because inflammation promotes the development of insulin resistance in tissues such as the liver, skeletal muscle, and adipose tissue by inhibiting insulin signal transduction [30], we propose that the improved insulin signaling in the liver might partly be attributable to the reduced inflammation observed in WEA-treated rats with NAFLD.